W © Telefonaktiebolaget LM Ericsson 2024 | Third quarter report 2024 | October 15, 2024 Ericsson Third quarter 2024 October 15, 2024 Third quarter 2024 This presentation contains forward-looking statements. Such statements are based on our current expectations and are subject to risks and uncertainties that could materially affect our business and results. Please read our earnings reports and our most recent annual report for a better understanding of these risks and uncertainties and please see the last pa ...

THIRD 2024 QUARTER INVESTOR TELECONFERENCE OCTOBER 11, 2024 1 SAFE HARBOR STATEMENT | --- | --- | |----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

| --- | --- | |-------|-------| | | | | | | | | | | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------| | | | | | | | 3Q24 Financial Highlights | | | | | | Revenue Growth: | 5 % | | Expense Growth: | 0 % | | Pre-tax Margin: | 33 % | | ...

3Q24 Financial Results October 11, 2024 © 2024 Wells Fargo Bank, N.A. All rights reserved. 3Q24 results Financial Results ROE: 11.7% ROTCE: 13.9%1 Efficiency ratio: 64%2 • Net income of $5.1 billion, or $1.42 per diluted common share, included: – $(447) million, or $(0.10) per share, of net losses on debt securities related to a repositioning of the investment securities portfolio • Revenue of $20.4 billion, down 2% – Net interest income of $11.7 billion, down 11% – Noninterest income of $8.7 billion, up 12 ...

JP MORGAN CHASE & CO. 3Q24 Financial Results October 11, 2024 3Q24 Financial highlights | --- | --- | --- | |---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------| | ROTCE 1 19% | CET1 capital ratios 2 Std. 15.3% \| Adv. 15.5% Total Loss-Absorbing Capacity 2 $544B | Std. RWA 3 $1.8T Ca ...

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|-------|-------|-------|-------|------------------|---------------------------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | First | | Fiscal Year 2025 -Quarter | | | | | | | | | | | Results | | | | | | | | | | | | October 10, 2024 | | | Disclaimer Preliminary Results and Forward-Looking Statements The Company's reported results are preliminary. The Company has not yet completed it ...

Saratoga Investment Corp. Fiscal Second Quarter 2025 Shareholder Presentation October 9, 2024 Steady Long-Term Growth and Performance in Q2 2025 Fiscal Second Quarter 2025 Highlights: • Continued high quality portfolio and solid performance • Investment quality remains solid • 99.7% of loan investments with highest internal rating and two residual non-accruals (0.3% of fair value / 0.4% of cost) • All four non-accrual or watchlist investments resolved during the quarter with decisive action • Return on equi ...

October 2024 NASDAQ: ACCD Accolade Inc. Investor Presentation | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

| --- | --- | |------------------------------------------------------|-------| | | | | AngioDynamics | | | First Quarter Fiscal Year 2025 Earnings Presentation | | | October 3, 2024 | | | --- ...

| --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|-------|------------------------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fiscal 2025 | | | | | | | | First-Quarter Results | | | | | | | | | | | | | | | | October 2, 2024 | | Forward-Looking Statements & Regulation G This presentation contains "forward-looking statements" relating to our business. These forward-looking statements, or other statements made by us, are made based on our exp ...